{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:35:00Z","timestamp":1793313300550,"version":"4.5.0"},"reference-count":110,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Telemed Telecare"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The COVID-19 pandemic has instigated the development of telemedicine-mediated provision of medications for opioid use disorder such as buprenorphine and methadone, referred to as TMOUD in this study. As services start to return to pre-pandemic norms, there is a debate around the role of TMOUD as addition to or replacement of the conventional cascade of care for people with opioid use disorder (PWOUD). This scoping review is designed to characterize existing TMOUD services and provide insights to enable a more nuanced discussion on the role of telemedicine in the care of PWOUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The literature search was conducted in OVID Medline, CINAHL, and PsycINFO, from inception up to and including April 2023, using the Joanna Briggs Institute methodology for scoping reviews. The review considered any study design that detailed sufficient descriptive information on a given TMOUD service. A data extraction form was developed to collect and categorize a range of descriptive characteristics of each discrete TMOUD model identified from the obtained articles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 45 articles met the inclusion criteria, and from this, 40 discrete TMOUD services were identified. In total, 33 services were US-based, three from Canada, and one each from India, Ireland, the UK, and Norway. Through a detailed analysis of TMOUD service characteristics, four models of care were identified. These were TMOUD to facilitate inclusion health, to facilitate transitions in care, to meet complex healthcare needs, and to maintain opioid use disorder (OUD) service resilience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Characterizing TMOUD according to its functional benefits to PWOUD and OUD services will help support evidence-based policy and practice. Additionally, particular attention is given to how digital exclusion of PWOUD can be mitigated against.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1357633x231195607","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T03:44:10Z","timestamp":1693799050000},"page":"500-514","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-7013","authenticated-orcid":false,"given":"Joseph","family":"Tay Wee Teck","sequence":"first","affiliation":[{"name":"University of St Andrews"},{"name":"Forward Leeds and Humankind Charity, Durham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3155-866X","authenticated-orcid":false,"given":"Jenna L","family":"Butner","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Baldacchino","sequence":"additional","affiliation":[{"name":"University of St Andrews"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_3_3_2","unstructured":"UNODC. World Drug Report: Executive summary and policy implications. Vienna: United Nations Office on Drugs and Crime https:\/\/www.unodc.org\/res\/wdr2022\/MS\/WDR22_Booklet_1.pdf (2022 accessed 26 January 2023)."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-021-00395-6"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6932a1"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108153"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100232"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1212"},{"key":"e_1_3_3_9_2","unstructured":"Wang J. Examining Low-Barrier Buprenorphine Treatment during COVID-19 for Individuals Experiencing Housing Insecurity and Homelessness https:\/\/dataspace.princeton.edu\/handle\/88435\/dsp01n583xz11f (2021 accessed 25 March 2023)."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2020-214401"},{"key":"e_1_3_3_11_2","first-page":"3","article-title":"Socioeconomic inequalities and COVID-19 \u2013 A review of the current international literature","volume":"5","author":"Wachtler B","year":"2020","unstructured":"Wachtler B, Michalski N, Nowossadeck E, et al. Socioeconomic inequalities and COVID-19 \u2013 A review of the current international literature. J Health Monit 2020; 5: 3\u201317.","journal-title":"J Health Monit"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32848-9"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2020-214720"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.52381"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108272"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.18543"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.639393"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2023.2167496"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2032"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0137-5"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.06.020"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4801-3"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S304566"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32893-3"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20633"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1967836"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2022.2026969"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00771-4"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067608"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2021.04.023"},{"key":"e_1_3_3_31_2","first-page":"321","article-title":"Managing opioid use disorder in primary care: PEER simplified guideline","volume":"65","author":"Korownyk C","year":"2019","unstructured":"Korownyk C, Perry D, Ton J, et al. Managing opioid use disorder in primary care: PEER simplified guideline. Canadian Family Physician 2019; 65: 321\u2013330.","journal-title":"Canadian Family Physician"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.17730\/1938-3525-79.4.292"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00676-8"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(22)00374-1"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2022.00803"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108124"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108037"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2020.02261"},{"key":"e_1_3_3_39_2","unstructured":"Peters MD Godfrey CM McInerney P et al. The Joanna Briggs Institute reviewers\u2019 manual 2015: methodology for JBI scoping reviews."},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186315"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/1468-0009.12584"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108777"},{"key":"e_1_3_3_44_2","first-page":"1","article-title":"Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine","volume":"43","author":"Brunet N","year":"2020","unstructured":"Brunet N, Moore D, Wischik D, et al. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Subst Abus 2020; 43: 1\u20138.","journal-title":"Subst Abus"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2022.2079140"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001034","article-title":"Providing low-barrier addiction treatment via a telemedicine consultation service during the COVID-19 pandemic in Los Angeles, county: An assessment 1 year later","volume":"17","author":"Kennedy AJ","year":"2023","unstructured":"Kennedy AJ, George JS, Rossetti G, et al. Providing low-barrier addiction treatment via a telemedicine consultation service during the COVID-19 pandemic in Los Angeles, county: An assessment 1 year later. J Addict Med 2023; 17: e64.","journal-title":"J Addict Med"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108312"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001079"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1037\/rmh0000206"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjinnov-2021-000816"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07955-x"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00394-z"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103768"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","unstructured":"McDonald R Bech AB Clausen T. Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiences. BMC Health Serv Res. Epub ahead of print 18 January 2023. DOI: 10.21203\/rs.3.rs-2212348\/v1.","DOI":"10.21203\/rs.3.rs-2212348\/v1"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.01.048"},{"key":"e_1_3_3_56_2","article-title":"Characterizing the use of telepsychiatry for patients with opioid use disorder and cooccurring mental health disorders in Ontario, Canada","volume":"2018","author":"LaBelle B","year":"2018","unstructured":"LaBelle B, Franklyn AM, Nguyen VPKH, et al. Characterizing the use of telepsychiatry for patients with opioid use disorder and cooccurring mental health disorders in Ontario, Canada. Int J Telemed Appl 2018; 2018: e7937610.","journal-title":"Int J Telemed Appl"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-022-00323-4"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.717"},{"key":"e_1_3_3_59_2","article-title":"Telemedicine in addictions: Feasibility randomised controlled trial","author":"Mayet S","unstructured":"Mayet S, Gledhill A, McCaw I, et al. Telemedicine in addictions: Feasibility randomised controlled trial. Heroin Addict Relat Clin Prob 2023; 25: 27\u201336.","journal-title":"Heroin Addict Relat Clin Prob"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102582"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.08.071"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2022.2069269"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000809"},{"key":"e_1_3_3_64_2","unstructured":"Public Health England. Research and analysis United Kingdom drug situation 2019: summary (Updated 31 March 2021) https:\/\/www.gov.uk\/government\/publications\/united-kingdom-drug-situation-focal-point-annual-report\/uk-drug-situation-2019-summary (2019 accessed 21 April 2023)."},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-018-0792-8"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15862"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109517"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108543"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20177"},{"key":"e_1_3_3_70_2","unstructured":"Hermes. Virtual MOUD Treatment: Virtual Point-of-Care Toxicology Testing to Accompany Virtual Medication Assisted Treatment for Opioid Use Disorder. Clinical Trial Registration NCT05448118 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05448118 (4 November 2022 accessed 21 November 2022)."},{"key":"e_1_3_3_71_2","unstructured":"Bruneau J Rehm J Wild TC et al. Telemedicine Support for Addiction Services: National Rapid Guidance Document. Montreal Quebec.: Canadian Research Initiative in Substance Misuse https:\/\/crism.ca\/wp-content\/uploads\/2020\/05\/CRISM-National-Rapid-Guidance-Telemedicine-V1.pdf (2020 accessed 6 March 2023)."},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000287"},{"key":"e_1_3_3_73_2","unstructured":"American Society of Addiction Medicine. Caring For Patients During The Covid-19 Pandemic: Adjusting Drug Testing Protocols https:\/\/downloads.asam.org\/sitefinity-production-blobs\/docs\/default-source\/guidelines\/covid-19\/11-adjusting-drug-testing-protocols_final.pdf?sfvrsn=5dba58c2_2 (2020 accessed 10 July 2023)."},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31959-1"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31869-X"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00572-7"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00438-4"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2182908"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07074-w"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109187"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108553"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109124"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108181"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.703685"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00578-1"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000791"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000836"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10669-0"},{"key":"e_1_3_3_89_2","article-title":"The necessity of a trauma-informed paradigm in substance use disorder services","volume":"107839032110364","author":"Bartholow LAM","year":"2021","unstructured":"Bartholow LAM, Huffman RT. The necessity of a trauma-informed paradigm in substance use disorder services. J Am Psychiatr Nurses Assoc 2021: 10783903211036496.","journal-title":"J Am Psychiatr Nurses Assoc"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00483-1"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000811"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diggeo.2022.100041"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2021.0130"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108273"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306767"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","unstructured":"Acharya A Izquierdo AM Gon\u00e7alves SF et al. Exploring county-level spatio-temporal patterns in opioid overdose related emergency department visits. PLOS ONE 17: e0269509. DOI: 10.1371\/journal.pone.0269509.","DOI":"10.1371\/journal.pone.0269509"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2149"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109049"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40352-023-00208-x"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1177\/0706743717711167"},{"key":"e_1_3_3_101_2","doi-asserted-by":"crossref","DOI":"10.3122\/jabfm.2021.S1.200207","article-title":"Designing and evaluating COVID-19 protocols for an office-based opioid treatment program in an urban underserved setting","volume":"34","author":"O\u2019Gurek DT","year":"2021","unstructured":"O\u2019Gurek DT. Designing and evaluating COVID-19 protocols for an office-based opioid treatment program in an urban underserved setting. J Am Board Fam Med: JABFM 2021; 34: S136\u2013S140.","journal-title":"J Am Board Fam Med: JABFM"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00233-x"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12805"},{"key":"e_1_3_3_104_2","first-page":"5","article-title":"Outcomes for patients receiving telemedicine-delivered medication-based treatment for opioid use disorder: A retrospective chart review","volume":"23","author":"Weintraub E","year":"2021","unstructured":"Weintraub E, Greenblatt AD, Chang J, et al. Outcomes for patients receiving telemedicine-delivered medication-based treatment for opioid use disorder: A retrospective chart review. Heroin Addict Relat Clin Probl 2021; 23: 5\u201312.","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmqr.2021.100013"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab285"},{"key":"e_1_3_3_107_2","unstructured":"Mehrotra A Wang B Snyder G. Telemedicine: What should the post- pandemic regulatory and payment landscape look like? Issue Brief. The Commonwealth Fund. 2020 Aug 5. Available at: https:\/\/www.senate.mn\/commiZees\/2021-2022\/3095CommiZee_on_Health_and_Human_Services_Finance_and_Policy\/Commonwealth%20Fund_Telemedicine.pdf"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001077"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00637-z"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103391"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103877"}],"container-title":["Journal of Telemedicine and Telecare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1357633X231195607","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1357633X231195607","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1357633X231195607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:17:03Z","timestamp":1777691823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1357633X231195607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/1357633X231195607"],"URL":"https:\/\/doi.org\/10.1177\/1357633x231195607","relation":{},"ISSN":["1357-633X","1758-1109"],"issn-type":[{"value":"1357-633X","type":"print"},{"value":"1758-1109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]}}}